... of TNF-α and IL-1 are other currently usedstrategies. Both cytokines are potent osteoclastogenicfactors, produced in inflammatory arthritis. Interestingly,clinical trials have shown that the ... 242Osteoprotegerin as inhibitor of osteoclastogenesisOsteoprotegerin (OPG) has emerged as one of the mostattractive tools to inhibit osteoclast formation during thepast years. The interaction of ... Nagashima M, Yamamoto M, Nishijima T, KatsumataS, Yoshino S: Bone resorption and inflammatory inhibition effi-cacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. J Rheumatol 2003,...